Form 4 for ASH ASHLAND INC.
Accepted 2026-07-29 16:30:04 ET · period of report 2026-07-27 · accession 0001193125-26-323842 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-07-29 16:30 | 2026-07-27 | ASH | Assis Alessandra Faccin | SVP, GM, Life Sciences | M - OptEx | $66.38 | +3,215 | 9,099 | +55% | +$213.4K |
| D | 2026-07-29 16:30 | 2026-07-27 | ASH | Assis Alessandra Faccin | SVP, GM, Life Sciences | F - Tax | $66.38 | -884 | 8,215 | -10% | -$58.7K |
| D | 2026-07-29 16:30 | 2026-07-27 | ASH | Assis Alessandra Faccin | SVP, GM, Life Sciences | M - OptEx | $0.00 | -3,215 | 9,646 | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-07-27 | M | A | 3,215 | $66.38 | 9,099 | D | — | — | (F1) Balance includes additional common stock or restricted stock units acquired in lieu of cash dividends. |
| 2 | Common | Common Stock | 2026-07-27 | F | D | 884 | $66.38 | 8,215 | D | — | — | (F2) Payment of tax liability by withholding securities incident to the vesting of Restricted Stock Units acquired pursuant to Ashland's incentive plan as approved by the shareholders and exempt pursuant to Rule 16b-3. |
| 3 | Derivative | Restricted Stock Unit | 2026-07-27 | M | D | 3,215 | $0.00 | 9,646 | D | — · — to — | 3,215 Common Stock | (F3) Each Restricted Stock Unit represents a right to receive one (1) share of Ashland Common Stock. (F4) On July 25, 2024, the Reporting Person was granted 15,234 restricted stock units, vesting over a three-year period, with 20% vesting on July 25, 2025, 20% vesting on July 25, 2026, and 60% vesting on July 25, 2027, provided that the Reporting Person remains in continuous employment with the Issuer. (F4) On July 25, 2024, the Reporting Person was granted 15,234 restricted stock units, vesting over a three-year period, with 20% vesting on July 25, 2025, 20% vesting on July 25, 2026, and 60% vesting on July 25, 2027, provided that the Reporting Person remains in continuous employment with the Issuer. (F1) Balance includes additional common stock or restricted stock units acquired in lieu of cash dividends. |